SCHEMBL23958352

SCHEMBL23958352

COc1cccc2c(=O)n(-c3ccccc3)c(Nc3cccnc3)nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 1/20 0.44
ALOX12 P18054 1/20 0.43
TNF P01375 1/20 0.43
LITAF Q99732 1/20 0.43
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
ABCB1 P08183 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958176 0.86 ALPL (0.39) G6PDALOX12LMNAALDH1A1KDM4E
SCHEMBL23958356 0.86 ALOX12 (0.48) G6PDALOX12LMNAKDM4EMAPT
SCHEMBL23958349 0.84 PDE7A (0.47) ALOX12MAPTRAB9AKMT2ARAD52
SCHEMBL23958201 0.84 ALOX12 (0.43) ALOX12LMNAMAPTABCG2KMT2A
SCHEMBL24111007 0.83 ALDH1A1 (0.42) G6PDALOX12LMNAALDH1A1KDM4E
SCHEMBL24110995 0.81 ALOX12 (0.57) G6PDALOX12MAPTRAB9AKMT2A
SCHEMBL24110979 0.79 CYP19A1 (0.52) G6PDALOX12ALDH1A1ABCB1ABCG2
SCHEMBL23958331 0.79 LOXL3 (0.47) ALOX12MAPTRAB9AABCG2KMT2A
SCHEMBL24110973 0.78 ALOX12 (0.47) G6PDALOX12MAPTRAB9AKMT2A
SCHEMBL24111000 0.77 ALOX12 (0.49) G6PDALOX12MAPTRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 G6PD 1971/4885ALOX12 3240/4885TNF 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.